Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$216M |
| 2 |
Charter Communications
CHTR
|
+$192M |
| 3 |
SLB Ltd
SLB
|
+$79.3M |
| 4 |
IBM
IBM
|
+$70.2M |
| 5 |
Newell Brands
NWL
|
+$67.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AFFX
Affymetrix Inc
AFFX
|
+$7.53B |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$447M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$229M |
| 4 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$208M |
| 5 |
SNDK
SANDISK CORP
SNDK
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.87% |
| 2 | Technology | 14.38% |
| 3 | Financials | 13.98% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Walt Disney
DIS
$187B
| $1.26B | 0.69% |
12,904,108
+576,058
| +5% | +$57.6M |
2013 Q2
12 quarters
|
|
27
Visa
V
$724B
| $1.22B | 0.66% |
16,503,927
+73,266
| +0.4% | +$5.74M |
2013 Q2
12 quarters
|
|
|
28
IBM
IBM
$214B
| $1.17B | 0.63% |
8,058,196
+490,467
| +6% | +$70.2M |
2013 Q2
12 quarters
|
|
29
Bank of America
BAC
$380B
| $1.14B | 0.62% |
86,281,468
-1,287,792
| -1% | -$18.1M |
2013 Q2
12 quarters
|
|
30
Altria Group
MO
$120B
| $1.1B | 0.6% |
15,939,788
-163,185
| -1% | -$10.5M |
2013 Q2
12 quarters
|
|
31
UnitedHealth
UNH
$340B
| $1.08B | 0.58% |
7,627,871
-248,970
| -3% | -$33.2M |
2013 Q2
12 quarters
|
|
32
Oracle
ORCL
$429B
| $1.06B | 0.57% |
25,859,372
-344,168
| -1% | -$13.7M |
2013 Q2
12 quarters
|
|
33
Citigroup
C
$217B
| $1.02B | 0.56% |
24,214,832
-442,738
| -2% | -$19.6M |
2013 Q2
12 quarters
|
|
34
Gilead Sciences
GILD
$187B
| $1.02B | 0.55% |
12,241,716
-169,130
| -1% | -$15M |
2013 Q2
12 quarters
|
|
35
Medtronic
MDT
$113B
| $1.01B | 0.55% |
11,646,127
-100,958
| -0.9% | -$8.16M |
2013 Q2
12 quarters
|
|
36
Bristol-Myers Squibb
BMY
$121B
| $987M | 0.54% |
13,440,140
-94,435
| -0.7% | -$6.67M |
2013 Q2
12 quarters
|
|
37
Amgen
AMGN
$224B
| $983M | 0.53% |
6,468,402
+24,129
| +0.4% | +$3.75M |
2013 Q2
12 quarters
|
|
38
Walmart Inc
WMT
$883B
| $956M | 0.52% |
39,363,240
-1,347,501
| -3% | -$31.2M |
2013 Q2
12 quarters
|
|
39
3M
MMM
$82.5B
| $940M | 0.51% |
6,429,811
+54,399
| +0.9% | +$7.67M |
2013 Q2
12 quarters
|
|
40
McDonald's
MCD
$166B
| $906M | 0.49% |
7,543,564
-246,352
| -3% | -$30.9M |
2013 Q2
12 quarters
|
|
|
41
SLB Ltd
SLB
$72.6B
| $901M | 0.49% |
11,415,943
+1,034,386
| +10% | +$79.3M |
2013 Q2
12 quarters
|
|
42
CVS Health
CVS
$110B
| $820M | 0.45% |
8,583,232
-333,808
| -4% | -$33.3M |
2013 Q2
12 quarters
|
|
43
AbbVie
ABBV
$489B
| $795M | 0.43% |
12,858,423
-192,758
| -1% | -$11.7M |
2013 Q2
12 quarters
|
|
44
Starbucks
SBUX
$103B
| $769M | 0.42% |
13,477,183
+72,103
| +0.5% | +$4.1M |
2013 Q2
12 quarters
|
|
45
Mastercard
MA
$516B
| $758M | 0.41% |
8,623,873
+47,922
| +0.6% | +$4.58M |
2013 Q2
12 quarters
|
|
46
Honeywell
HON
$65.8B
| $751M | 0.41% |
7,197,892
-14,010
| -0.2% | -$1.44M |
2013 Q2
12 quarters
|
|
47
Qualcomm
QCOM
$187B
| $737M | 0.4% |
13,776,449
-287,464
| -2% | -$15.1M |
2013 Q2
12 quarters
|
|
|
AGN
48
DELISTED
Allergan plc
AGN
| $736M | 0.4% |
3,192,344
-46,627
| -1% | -$10.8M |
2015 Q3
3 quarters
|
|
49
Boeing
BA
$150B
| $697M | 0.38% |
5,376,249
-148,098
| -3% | -$19.3M |
2013 Q2
12 quarters
|
|
50
Eli Lilly
LLY
$1.05T
| $657M | 0.36% |
8,357,914
-28,151
| -0.3% | -$2.12M |
2013 Q2
12 quarters
|
|
Similar funds
Geode Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Geode Capital Management held 4,187 positions worth $184B, down 2.4% from $188B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Geode Capital Management withdrew a net $8.49B in Q2 2016, closing 127 positions and reducing 984 holdings. Its most notable exit was Affymetrix Inc, an estimated $7.53B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Geode Capital Management opened a new position in S&P Global worth $215M.
- Geode Capital Management's largest Q2 2016 buy was S&P Global: 2,009,728 shares worth $215M.
- Geode Capital Management added most to Charter Communications in Q2 2016, an estimated $192M increase.
- Geode Capital Management's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $72.2M.
- Geode Capital Management fully exited Affymetrix Inc in Q2 2016, selling an estimated $7.53B.
- Geode Capital Management's ten largest holdings make up 15% of its $184B portfolio in Q2 2016.
- Geode Capital Management opened 96 new positions and closed 127 in Q2 2016.
- Geode Capital Management's portfolio value fell 2.4% quarter-over-quarter to $184B.
Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.